Emerging Threats: Supply Chain, Logistics and Domestic Response

The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) partners with industry to ensure the nation’s preparedness for chemical, biological, radiological, and nuclear threats, as well as emerging infectious disease. Experts from H-CORE/ASPR, BARDA, NIAID, DOD, FDA, SNS and Industry will provide key insight from lessons learned from the COVID pandemic in the supply chain, MCM development, domestic warm-base for manufacturing to ensure our nations preparedness for future pandemics. Panelists will discuss the biodefense strategy, funding needed to ensure domestic preparedness, and insight into future priorities of their respective agencies to enhance the availability of medical countermeasure for use for future disasters and emergencies.